» Articles » PMID: 1889045

Factors Promoting Acute and Chronic Diseases Caused by Yersiniae

Overview
Specialty Microbiology
Date 1991 Jul 1
PMID 1889045
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

The experimental system constructed with the medically significant yersiniae provides a powerful basic model for comparative study of factors required for expression of acute versus chronic disease. The system exploits the close genetic similarity between Yersinia pestis, the etiological agent of bubonic plague, and enteropathogenic Yersinia pseudotuberculosis and Yersinia enterocolitica. Y. pestis possesses three plasmids, of which one, shared by the enteropathogenic species, mediates a number of virulence factors that directly or indirectly promote survival within macrophages and immunosuppression. The two remaining plasmids are unique and encode functions that promote acute disease by enhancing bacterial dissemination in tissues and resistance to phagocytosis by neutrophils and monocytes. These properties are replaced in the enteropathogenic yersiniae by host cell invasins and an adhesin which promote chronic disease; the latter are cryptic in Y. pestis. Additional distinctions include specific mutational losses in Y. pestis which result in loss of fitness in natural environments plus gain of properties that facilitate transmission and infection via fleabite.

Citing Articles

Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials.

Parums D Med Sci Monit. 2025; 31:e948672.

PMID: 40022523 PMC: 11881517. DOI: 10.12659/MSM.948672.


Human genetic variation reveals FCRL3 is a lymphocyte receptor for .

Keener R, Shi S, Dalapati T, Wang L, Reinoso-Vizcaino N, Luftig M bioRxiv. 2024; .

PMID: 39677730 PMC: 11643160. DOI: 10.1101/2024.12.05.626452.


Toxin-linked mobile genetic elements in major enteric bacterial pathogens.

Panwar S, Kumari S, Verma J, Bakshi S, Narendrakumar L, Paul D Gut Microbiome (Camb). 2024; 4:e5.

PMID: 39295911 PMC: 11406385. DOI: 10.1017/gmb.2023.2.


Progress on the research and development of plague vaccines with a call to action.

Williamson E, Kilgore P, Hendrix E, Neil B, Sha J, Chopra A NPJ Vaccines. 2024; 9(1):162.

PMID: 39242587 PMC: 11379892. DOI: 10.1038/s41541-024-00958-1.


Trojan horselike T6SS effector TepC mediates both interference competition and exploitative competition.

Song L, Xu L, Wu T, Shi Z, Kareem H, Wang Z ISME J. 2024; 18(1).

PMID: 38365238 PMC: 10833071. DOI: 10.1093/ismejo/wrad028.


References
1.
Kapperud G, Namork E, Skurnik M, Nesbakken T . Plasmid-mediated surface fibrillae of Yersinia pseudotuberculosis and Yersinia enterocolitica: relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun. 1987; 55(9):2247-54. PMC: 260686. DOI: 10.1128/iai.55.9.2247-2254.1987. View

2.
Bolin I, Forsberg A, Norlander L, Skurnik M, Wolf-Watz H . Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp. Infect Immun. 1988; 56(2):343-8. PMC: 259286. DOI: 10.1128/iai.56.2.343-348.1988. View

3.
Goguen J, Yother J, Straley S . Genetic analysis of the low calcium response in Yersinia pestis mu d1(Ap lac) insertion mutants. J Bacteriol. 1984; 160(3):842-8. PMC: 215785. DOI: 10.1128/jb.160.3.842-848.1984. View

4.
Cornelis G, Laroche Y, Balligand G, Sory M, Wauters G . Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis. 1987; 9(1):64-87. DOI: 10.1093/clinids/9.1.64. View

5.
Sample A, Brubaker R . Post-translational regulation of Lcr plasmid-mediated peptides in pesticinogenic Yersinia pestis. Microb Pathog. 1987; 3(4):239-48. DOI: 10.1016/0882-4010(87)90057-x. View